THE IMPORTANCE OF DISEASE PREVALENCE IN HIV TESTING
Why not test everyone for HIV infection? Because all screening tests have a
property known as positive predictive value -- the probability that a positive test result is
truly positive. Positive predictive value is greatly influenced by the prevalence of the
disease or infection in the population being tested. Why this is so is shown by calculating
the positive predictive value for the same test when applied to a population in which HIV
infection is highly prevalent as compared to population in which the prevalence is low.
Consider the example of a high-prevalence population -- injection drug users in a
major city in which half the drug users are infected (i.e., the prevalence of HIV in the
population is 50%). For convenience, the size of the population is said to be 100,000.
That means 50,000 people will be infected and 50,000 uninfected. The text used in the
example will have a specificity of 99.9% -- it will yield 1 false positive per 1,000 people
tested, or 50 false positives per 50,000 people tested. The positive predictive value is
calculated as follows:
Positive predictive value | = |
True positives
True positives + False positives
49,950
50,000 |
= 99.9% |
This result means that a positive test result has a 99.9% chance of being a true
positive. But the probability changes when the same calculation is applied to a population
with a low prevalence of infection. Take, for example, self selected and previously
tested blood donors from the general population. Here the prevalence of infection might
be 1 case per 100,000 people.
Thus, for every 100,000 people, 1 person is infected and 99.999 are uninfected. If
the test has a specificity of 99.9%, it means 0.1% -- about 100 of the test results will be
false positives. Now calculate the positive predictive value:
Positive predictive value | = |
True positives
True positives + False positives
1
101 |
= 1.0% |
This means that a positive test result in this population has only a 1% chance of being a
true positive!